Search

everythinglearnresearchcommunity

for

Search:↓

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

More men than women have hair loss, it's often inherited, and it's linked with higher testosterone levels. There's been a rise in female hair loss patients.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Fat tissue can potentially treat a common form of hair loss called androgenic alopecia.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Spironolactone may help reduce hair loss in androgenic alopecia.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

The document outlines a method for diagnosing hair loss and suggests specific treatments based on the diagnosis.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Hair changes can indicate systemic diseases or medication effects.

Skin health and diseases are closely linked to metabolic processes.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Hair loss can be treated based on its type and cause, improving quality of life.

Men may have a condition similar to PCOS, possibly indicated by early hair loss.

Spironolactone does not increase the risk of breast cancer recurrence.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.